Mitigating Lipotoxicity: A Potential Mechanism to Delay Chronic Kidney Disease Progression Using Current...

Area of Science:

• Nephrology
• Metabolic Disorders
• Cellular Biology

Background:

• Lipotoxicity, characterized by excessive lipid accumulation in non-adipose tissues, is a key driver of metabolic disorders such as insulin resistance, obesity, and chronic kidney disease (CKD).
• It exacerbates renal injury through mechanisms including endoplasmic reticulum (ER) stress, mitochondrial dysfunction, impaired autophagy, inflammation, and oxidative stress, damaging renal cells.
• While current renoprotective drugs like RAS inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, and NS-MRAs show promise, their precise mechanisms in mitigating lipotoxicity remain incompletely understood.

Purpose of the Study:

• This review aims to elucidate the proposed mechanisms by which pharmacological therapies may alleviate lipotoxicity in the context of CKD.
• It examines the cellular responses to lipid dysregulation and their impact on renal health.
• The review emphasizes the need for further research to clarify these pathways and their clinical relevance in treating kidney disease.

Main Methods:

• A comprehensive review of preclinical evidence and existing literature on lipotoxicity and its therapeutic interventions in CKD.
• Analysis of cellular mechanisms involved in lipid dysregulation, including ER stress, mitochondrial dysfunction, and oxidative stress.
• Examination of the potential renoprotective effects of pharmacological agents and lipid-lowering drugs.

Main Results:

• Emerging preclinical data suggest that therapies may attenuate lipotoxicity by enhancing fatty acid oxidation (FAO), reducing cholesterol biosynthesis and de novo lipogenesis.
• These interventions may also exert beneficial effects through anti-inflammatory and antioxidant actions, alongside improvements in mitochondrial function.
• These mechanisms are hypothesized to be crucial in slowing the progression of CKD.

Conclusions:

• Pharmacological therapies and lipid-lowering agents show potential in ameliorating lipotoxicity, a significant factor in CKD progression.
• Key mechanisms include modulating lipid metabolism pathways and mitigating cellular stress responses.
• Further investigation is essential to fully understand these pathways and translate these findings into effective clinical strategies for kidney disease management.